SC
GILD icon

Sapient Capital’s Gilead Sciences GILD Stock Holding History

Sapient Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$24.5M Sell
164,171
-944
-0.6% -$132K 0.33% 38
2026
Q2 		$20.9M Buy
165,115
+2,289
+1% +$302K 0.27% 53
2026
Q1 		$22.7M Sell
162,826
-10,520
-6% -$1.47M 0.34% 39
2025
Q4 		$21.3M Sell
173,346
-1,732
-1% -$210K 0.3% 54
2025
Q3 		$19.7M Sell
175,078
-8,077
-4% -$918K 0.3% 55
2025
Q2 		$20.3M Sell
183,155
-2,205
-1% -$235K 0.36% 52
2025
Q1 		$20.8M Buy
185,360
+182,774
+7,068% +$18.9M 0.41% 53
2024
Q4 		$239K Buy
2,586
+44
+2% +$3.96K ﹤0.01% 338
2024
Q3 		$213K Buy
+2,542
New +$194K ﹤0.01% 365
2024
Q1 		– Sell
-3,086
Closed -$250K – 378
2023
Q4 		$250K Buy
+3,086
New +$240K 0.01% 332

Other funds holding GILD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

Sapient Capital's GILD Position: Q3 2026 in Review

Sapient Capital reduced its Gilead Sciences (GILD) stake by 0.57% in Q3 2026, selling an estimated $132K and leaving 164,171 shares worth $24.5M. The position accounts for 0.33% of the portfolio, ranked #38.

Sapient Capital first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Sapient Capital held 164,171 shares of Gilead Sciences worth $24.5M as of Q3 2026.
  • Sapient Capital sold 944 Gilead Sciences shares in Q3 2026, an estimated $132K.
  • Gilead Sciences made up 0.33% of Sapient Capital's portfolio in Q3 2026, its #38 holding.
  • Sapient Capital first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Sapient Capital's 13F filing for Q3 2026, filed 8 Oct 2026.